Serum Adalimumab Levels After Induction Are Associated With Long-Term Remission in Children With Inflammatory Bowel Disease

Introduction: Adalimumab is effective in inducing and maintaining remission in children with inflammatory bowel diseases (IBD). Therapeutic drug monitoring is an important strategy to maximize the response rates, but data on the association of serum adalimumab levels are lacking. This study aimed to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pediatr
Main Authors: Lucafò, Marianna, Curci, Debora, Bramuzzo, Matteo, Alvisi, Patrizia, Martelossi, Stefano, Silvestri, Tania, Guastalla, Veronica, Labriola, Flavio, Stocco, Gabriele, Decorti, Giuliana
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Pediatrics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8129012/
https://ncbi.nlm.nih.gov/pubmed/34017806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fped.2021.646671
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados